CN108498615A - 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 - Google Patents
一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 Download PDFInfo
- Publication number
- CN108498615A CN108498615A CN201810696251.6A CN201810696251A CN108498615A CN 108498615 A CN108498615 A CN 108498615A CN 201810696251 A CN201810696251 A CN 201810696251A CN 108498615 A CN108498615 A CN 108498615A
- Authority
- CN
- China
- Prior art keywords
- parts
- eye
- health
- propolis
- chinese herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001508 eye Anatomy 0.000 title claims abstract description 101
- 239000003814 drug Substances 0.000 title claims abstract description 40
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 24
- 241000241413 Propolis Species 0.000 claims abstract description 23
- 229940069949 propolis Drugs 0.000 claims abstract description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 22
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 241001113925 Buddleja Species 0.000 claims abstract description 12
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 claims abstract description 12
- 244000192528 Chrysanthemum parthenium Species 0.000 claims abstract description 12
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 12
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 12
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 12
- 241000756943 Codonopsis Species 0.000 claims abstract description 12
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 12
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 12
- 241000195955 Equisetum hyemale Species 0.000 claims abstract description 12
- 241000287828 Gallus gallus Species 0.000 claims abstract description 12
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 235000003805 Musa ABB Group Nutrition 0.000 claims abstract description 12
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract description 12
- 235000015266 Plantago major Nutrition 0.000 claims abstract description 12
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 12
- 235000010674 Prunella vulgaris Nutrition 0.000 claims abstract description 12
- 235000008384 feverfew Nutrition 0.000 claims abstract description 12
- 229960003080 taurine Drugs 0.000 claims abstract description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 11
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims abstract description 11
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 11
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 11
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims abstract description 11
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 11
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims abstract description 11
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 11
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 11
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 11
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 11
- 229940116229 borneol Drugs 0.000 claims abstract description 11
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 11
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000011187 glycerol Nutrition 0.000 claims abstract description 11
- 229960000310 isoleucine Drugs 0.000 claims abstract description 11
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940041616 menthol Drugs 0.000 claims abstract description 11
- 239000004474 valine Substances 0.000 claims abstract description 11
- 229960005375 lutein Drugs 0.000 claims abstract description 9
- 235000012680 lutein Nutrition 0.000 claims abstract description 9
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 9
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 9
- 239000001656 lutein Substances 0.000 claims abstract description 9
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 9
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 9
- 229960004365 benzoic acid Drugs 0.000 claims abstract description 4
- 229960003136 leucine Drugs 0.000 claims abstract description 4
- 229960004295 valine Drugs 0.000 claims abstract description 4
- 241000208340 Araliaceae Species 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000005538 encapsulation Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 241000411851 herbal medicine Species 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 208000002177 Cataract Diseases 0.000 abstract description 10
- 230000036541 health Effects 0.000 abstract description 10
- 208000001491 myopia Diseases 0.000 abstract description 9
- 230000004379 myopia Effects 0.000 abstract description 8
- 230000001976 improved effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 229930003448 Vitamin K Natural products 0.000 abstract description 2
- 230000003796 beauty Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract description 2
- 201000008525 senile cataract Diseases 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 235000019168 vitamin K Nutrition 0.000 abstract description 2
- 239000011712 vitamin K Substances 0.000 abstract description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract description 2
- 229940046010 vitamin k Drugs 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000004438 eyesight Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 208000003464 asthenopia Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 208000030533 eye disease Diseases 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000004304 visual acuity Effects 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000283207 Indigofera tinctoria Species 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010047571 Visual impairment Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000029257 vision disease Diseases 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 102000014824 Crystallins Human genes 0.000 description 1
- 108010064003 Crystallins Proteins 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000012946 outsourcing Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001116 retinal neuron Anatomy 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 210000001210 retinal vessel Anatomy 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000003956 synaptic plasticity Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Animal Husbandry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法,属于保健品领域,是由人参、党参、密蒙花、鸡爪黄连、艾叶、黄柏、木贼、白菊花、川芎、夏枯草、桑叶、决明子、车前子、酒制蜂胶、防风、牛磺酸、亮氨酸、异亮氨酸、缬氨酸、酶解珍珠粉、蓝莓提取物、叶黄素、花青素、薄荷脑、冰片、苯甲酸纳和甘油制得。发明中各物质相互配合,可改善眼部组织的血液循环和代谢,缓解眼部不适,促进健康,适合于眼干、眼涩、眼胀、迎风流泪、近视等眼部不适亚健康人群,同时对老年白内障具有良好的防治效果。本发明还具备淡化黑眼圈、消除眼袋等美容功效。本发明的中药保健贴使用简单安全,易于推广普及。
Description
技术领域
本发明属于保健品领域,具体涉及一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法。
背景技术
青少年由于学习压力大,并缺乏正确科学的用眼知识,是近视、远视、散光等眼部问题的普发人群。中青年群体,长期使用电脑,工作压力大,加班熬夜等极易导致眼胀、眼涩、黑眼圈等眼部问题。而老年人极易患白内障,是由于老年人随着年龄的增长,免疫功能逐渐下降,外伤、辐射等都能引起晶状体蛋白质变性而发生浑浊,导致白内障。随着电脑、电视、手机等电子产品的普及,眼睛休息的时间越来越短,很多人都会出现眼干涩、肿胀、畏光、酸痛、流泪、异物感、眼痉挛、视力下降、黑眼圈、眼部皱纹加深等眼部问题,严重者伴有头晕头痛、恶心呕吐等神经官能症状,直接影响人们的学习和生活。因此眼部的保健和养护十分重要。
目前眼部保健的方法主要有保持定期休息、做眼保健操以及使用眼部药水眼贴膜等方式。前两种方式可以一定程度缓解眼部疲劳,但是人们工作、学习压力大节奏快,不能保证坚持定期休息和做眼保健操,而大多的眼药水中含有防腐剂等化学物质,长期使用会出现一定的副作用。而市售的很多眼贴膜产品,主要以保湿滋养为主。其成分多含有大量化学成分,不仅眼睛得不到原有的保养作用,反而会刺激眼睛。中医认为:视疲劳、干眼症、慢性结膜炎包括青少年近视,原因主要是眼球局部慢性炎症病变,“余热未清,隐伏局部”所致;或是由于人体整体阴阳失衡,导致“清气不升,目窍失养”,进一步带来眼局部的病变。中医以治本为原则,以中药制造护眼贴已经申请了发明专利,但是配置组份方法不同,其功效也会很不相同。
发明内容
本发明为缓解视疲劳、眼干、眼涩、眼胀以及治疗近视、白内障等眼部疾病,提供一种中药眼保健贴及其制备方法,利用中药组合物之间的配比关系,疏通眼部经络,促进眼部血液循环,从而缓解眼部不适。
本发明所采用的技术方案是:
一种基于一氧化氮原理改善眼睛的中药眼保健贴,是由以下重量份的原料制成:人参160-200份、党参120-160份、密蒙花100-120份、鸡爪黄连80-100份、艾叶60-100份、黄柏60-100份、木贼50-70份、白菊花100-120份、川芎50-70份、夏枯草50-70份、桑叶50-70份、决明子60-100份、车前子60-100份、酒制蜂胶20-40份、防风20-40份、牛磺酸3-5份、亮氨酸3-7份、异亮氨酸3-7份、缬氨酸3-7份、酶解珍珠粉3-5份、蓝莓提取物3-5份、叶黄素3-5份、花青素4-8份、薄荷脑4-8份、冰片4-8份、苯甲酸纳3-5份和甘油6-10份。
优选的,一种基于一氧化氮原理改善眼睛的中药眼保健贴,是由以下重量份的原料制成:人参180份、党参140份、密蒙花110份、鸡爪黄连90份、艾叶80份、黄柏80份、木贼60份、白菊花110份、川芎60份、夏枯草60份、桑叶60份、决明子80份、车前子80份、酒制蜂胶30份、防风30份、牛磺酸4份、亮氨酸5份、异亮氨酸5份、缬氨酸5份、酶解珍珠粉4份、蓝莓提取物4份、叶黄素4份、花青素6份、薄荷脑6份、冰片6份、苯甲酸纳4份和甘油8份。
一种基于一氧化氮原理改善眼睛的中药眼保健贴,其制备方法如下:
(1)按比例称取人参、党参、密蒙花、鸡爪黄连、艾叶、黄柏、木贼、白菊花、川芎、夏枯草、桑叶、决明子、车前子、酒制蜂胶和防风分别粉碎后加入5倍重量的蒸馏水,醇提水沉二次,合并提取液,取上清液,得到中草药混合液;
(2)按比例称取牛磺酸、亮氨酸、异亮氨酸、缬氨酸、酶解珍珠粉、蓝莓提取物、叶黄素、花青素、薄荷脑、冰片、苯甲酸纳和甘油加入到步骤(1)所得中药混合液,并加入两倍重量的蒸馏水,搅拌均匀,将切割成片的无纺布浸渍溶液中24-48小时,装袋封装后得到中药眼保健贴。
其中酒制蜂胶的制备方法如下:将蜂胶用5倍重量份90-95%乙醇浸泡24-36小时,过滤,滤液经浓缩、干燥、粉碎和研磨后,过200目筛得酒制蜂胶。
所述酶解珍珠粉为采用酶解工艺制备的超细珍珠粉,其粒径为80μm以下。所述蓝莓提取物为市购成品。
本发明所述眼保健贴的使用方法:清洁眼部,将眼保健贴敷于眼部,每天2-3次,每次保持10-30min,1个月为一疗程。眼睛的脉络膜和视网膜的血管内皮细胞、视杆细胞外节段、视网膜神经元、脉络膜 血管旁神经纤维、视网膜色素上皮细胞等,均可能产生一氧化氮。一氧化氮作为新发现的神经递质,广泛分布于视觉系统三级神经元,在正常情况下,一氧化氮与一些神经递质和神经肽共同参与视觉发育、视信息的整合及传递,一氧化氮参与视觉神经系统的突触可塑性。许多研究表明一氧化氮可以扩张血管,增加血流量,起到调节中枢神经系统以及眼球内外的动脉和视网膜毛细血管的血液循环的作用。通过调节血液循环,可改善因长期使用眼睛造成的眼部疲劳、视力受损等症状。本发明中各物质相互作用,显著提高眼部一氧化氮含量,添加白菊花、党参、川芎、黄柏和鸡爪黄连,可合理调控眼部的一氧化氮含量,显著降低生长细胞因子和炎症因子水平,对肾脏细胞产生保护作用,进而保护肾脏。蓝莓提取物、叶黄素和花青素活化视网膜,强化视网膜血管,防止眼球疲劳,提高视力。牛磺酸提高神经传导和视觉技能,保护视网膜,促进免疫球蛋白的合成。酶解珍珠粉富含多种人体必需营养物质以及30多种微量元素,可内服亦可外用,有清肝、退翳、明目的功效。中医眼科临床常用于治疗角膜病、青少年近视、视疲劳及老年白内障。研究表明:从珍珠贝层中提取多种氨基酸制成眼药,治疗初发期老年性白内障有一定疗效,珍珠总卟啉成分及其分离后产物,能抑制自由基反应,具有一定的抗衰老作用。
视疲劳、近视眼等眼部疾病多为肝血不足,肝肾阴虚所致,应当以活血通络,清肝明目为治则。本发明选用人参为君药,可以扩张皮肤毛细血管,促进眼部皮肤血液循环,从而缓解眼部不适。辅以艾叶、决明子、密蒙花、桑叶、车前子通经活络、清热解毒、清肝明目,补阳气。以木贼、夏枯草和酒制蜂胶疏风散热,散结消肿,治目生云翳迎风流泪等症状。
人参自古誉为“百草之王”“滋阴补生,扶正固本”之极品,含多种皂甙和多糖类成分,浸出液可被皮肤缓慢吸收且无不良刺激,能扩张皮肤毛细血管,促进皮肤血液循环,增加皮肤营养,调节皮肤的水油平衡,防止皮肤脱水、硬化、起皱,人参活性物质抑制黑色素的还原性能,使皮肤洁白光滑,能增强皮肤弹性,使细胞获得新生,是护肤美容的极品。配合利用酒制蜂胶抗氧化,分解色素沉淀以及滋补等的作用,可有效缓解黑眼圈,淡化眼部皱纹、消除眼袋,起到美容养颜的功效。
本发明的有益效果:本发明根据中医理论及药物透皮吸收技术,精选药物配方,利用强吸水性无纺布具有使药物在眼皮肤停留时间长的特点,结合传统及现代工艺精制得到眼保健贴,通过眼部周围经络给药并起作用,作用直接,具有通经活血、清肝明目、醒神通窍之功效。通过长久均衡释放药物,刺激眼部周围神经感受器和末梢血管,有效改善眼部周围血液循环和内神经调节,改善眼部组织的血液循环和代谢,恢复眼肌的生理调节,从而缓解眼部不适,促进健康。本发明可有效缓解视疲劳、治疗近视、白内障等眼部疾病,适合青少年、中年以及老年群体使用,具有普适性。同时本发明还具备淡化黑眼圈,消除眼袋以及淡化眼部皱纹等美容功效,特别适合女性群体使用。本发明的中药保健贴使用简单安全,无毒副作用,易于推广普及。
具体实施方式
下面列举一部分具体实施例对本发明进行说明,有必要在此指出的是以下具体实施例只用于对本发明作进一步说明,不代表对本发明保护范围的限制。其他人根据本发明做出的一些非本质的修改和调整仍属于本发明的保护范围。
实施例1
一种基于一氧化氮原理改善眼睛的中药眼保健贴,是由以下重量份的原料制成:人参160份、党参120份、密蒙花100份、鸡爪黄连80份、艾叶60份、黄柏60份、木贼50份、白菊花100份、川芎50份、夏枯草50份、桑叶50份、决明子60份、车前子60份、酒制蜂胶20份、防风20份、牛磺酸3份、亮氨酸3份、异亮氨酸3份、缬氨酸3份、酶解珍珠粉3份、蓝莓提取物3份、叶黄素3份、花青素4份、薄荷脑4份、冰片4份、苯甲酸纳3份、甘油6份。
一种基于一氧化氮原理改善眼睛的中药眼保健贴,其制备方法如下:
(1)按比例称取人参、党参、密蒙花、鸡爪黄连、艾叶、黄柏、木贼、白菊花、川芎、夏枯草、桑叶、决明子、车前子、酒制蜂胶和防风分别粉碎后加入5倍重量的蒸馏水,醇提水沉二次,合并提取液,取上清液,得到中草药混合液;
(2)按比例称取牛磺酸、亮氨酸、异亮氨酸、缬氨酸、酶解珍珠粉、蓝莓提取物、叶黄素、花青素、薄荷脑、冰片、苯甲酸纳和甘油加入到步骤(1)所得中药混合液,并加入两倍重量的蒸馏水,搅拌均匀,将切割成片的无纺布浸渍溶液中24-48小时,装袋封装后得到中药眼保健贴。
其中,步骤(1)中酒制蜂胶可以外购成品,也可自制。
酒制蜂胶自制的具体方法如下:将蜂胶用5倍重量份90-95%乙醇浸泡24-36小时,过滤,滤液浓缩低温干燥粉碎研磨后,过200目筛得酒制蜂胶。
所述酶解珍珠粉为采用酶解工艺制备的超细珍珠粉,其粒径为80μm以下。所述蓝莓提取物为市购成品。
本发明所述眼保健贴的使用方法:清洁眼部,将眼保健贴敷于眼部,每天2-3次,每次保持10-30min,1个月为一疗程。
实施例2
一种基于一氧化氮原理改善眼睛的中药眼保健贴,是由以下重量份的原料制成:人参180份、党参140份、密蒙花110份、鸡爪黄连90份、艾叶80份、黄柏80份、木贼60份、白菊花110份、川芎60份、夏枯草60份、桑叶60份、决明子80份、车前子80份、酒制蜂胶30份、防风30份、牛磺酸4份、亮氨酸5份、异亮氨酸5份、缬氨酸5份、酶解珍珠粉4份、蓝莓提取物4份、叶黄素4份、花青素6份、薄荷脑6份、冰片6份、苯甲酸纳4份、甘油8份。
其余同实施例1。
实施例3
一种基于一氧化氮原理改善眼睛的中药眼保健贴,是由以下重量份的原料制成:人参200份、党参160份、密蒙花120份、鸡爪黄连100份、艾叶100份、黄柏100份、木贼70份、白菊花120份、川芎70份、夏枯草70份、桑叶70份、决明子100份、车前子100份、酒制蜂胶40份、防风40份、牛磺酸5份、亮氨酸7份、异亮氨酸7份、缬氨酸7份、酶解珍珠粉5份、蓝莓提取物5份、叶黄素5份、花青素8份、薄荷脑8份、冰片8份、苯甲酸纳5份、甘油10份。
其余同实施例1。
实验例1
本组观察50例,100只眼,分男、女两组,其中男25例,女25例;年龄最小者18岁,年龄最大者65岁,平均年龄35岁。症见:眼胀、眼痛、酸困、干涩、阅读不持久、视物模糊、异物感、烧灼感、流泪、黑眼圈等症状的患者。
治疗方法:清洗面部,闭目,将本发明实施例1所得中药眼保健贴贴于眼部, 保留10- 30min, 每天2 -3次, 疗程一个月。治疗期间不使用其它治疗方法和药物。
疗效标准
完全缓解:治疗后自觉症状消失
部分缓解:治疗后自觉症状减轻
无效:治疗后自觉症状无明显变化
有效率:完全缓解和部分缓解人数占观察人数的百分比
治疗结果如表1所示
表1 实验结果
该50例患者经过治疗后,其眼胀、眼涩、眼痛等眼部不适症状得到缓解,有效率达到100%。其中黑眼圈患者症状减轻明显,均到达完全缓解的指标要求。
实验例2
本组观察白内障患者50例,分成两组;治疗组25例,年龄50-75岁,平均65岁,病程6月-3年;对照组25例,年龄50-75岁,平均65岁,病程6月-3年。两组一般资料比较差异无统计学意义(P> 0.05),具有可比性。
治疗方法:清洗面部,闭目,将本发明实施例2所得中药眼保健贴贴于眼部,保留10- 30min, 每天2 -3次,疗程六个月。对照组采用市售普通眼贴膜,按照使用说明书使用,疗程同为六个月。各组实验期间均不使用其它治疗方法和药物。
疗效标准
完全缓解:治疗后视物清晰,视力正常
部分缓解:治疗后视物模糊情况减轻,视力改善
无效:治疗后症状无明显变化
有效率:完全缓解和部分缓解人数占观察人数的百分比
治疗结果如表2所示
表2实验结果
根据实验结果可知,本发明实施例2所制备眼贴膜对于白内障患者有一定的治疗效果,且效果较明显,总有效率达到100%。而普通眼贴膜对白内障的治疗效果欠佳。
临床资料:
选择医院门诊近视患者200例,随机分成两组;治疗组100例,其中男50例,女50例,年龄8-35岁,平均20岁,病程2月-6年;对照组100例,其中男50例, 女50例,年龄8-35岁,平均20岁,病程2月-6年。两组一般资料比较差异无统计学意义(P> 0.05),具有可比性。
诊断标准:患者的裸眼视力低于4.8(标准对数视力表灯SLD-II-型);经裂隙灯、眼底镜检查排除器质性病变,确诊为近视;并符合1985年中华医学会眼科学会眼屈光学组制订的真、假性近视的定义与分类标准(参见《现代眼科手册》,北京,人民卫生出版社,1993年,第563-564页)。
排除标准:1)合并有心血管、脑血管、肝、肾和造血系统等严重全身性疾病;精神病患者;2)长期服用其它有关药物治疗或应用其它治疗方法,未能完成治者;3)出现病理性近视的眼底改变及视功能明显受损者;4)患眼合并其它眼病,影响疗效判定者;5)不符合纳入标准,未按规定按时治疗,无法判定疗效或资料不全等影响疗效判断者。
治疗方法:清洗面部,闭目,将本发明实施例2所得中药眼保健贴贴于眼部, 保留10- 30min, 每天2 -3次, 疗程两个月。对照组采用市售普通眼贴膜,按照使用说明书使用,疗程同为两个月。治疗期间均不使用其它治疗方法和药物。
治疗判定标准
治愈:视力提高达到1.0或以上者;
显效:视力提高2级以上但未达到1.0者;
有效:视力提高1-2级者;
无效:视力提高不到1级或无增高者。
注:国际标准对数视力表为准,1级为1行。
治愈率=(治愈/总人数)×100%。
总有效率=[(治愈+显效+有效)/总人数]×100%。
统计学方法:采用SPSS17.0统计软件进行统计学分析,计量资料以均数±标准差( ±s)表示,采用t检验,计数资料率的比较采用检验。
治疗结果:见表3
表3应用本发明实施例2眼保健贴后的治疗结果
组别 | 治愈/人 | 显效/人 | 有效/人 | 无效/人 | 治愈率/% | 总有效率/% |
治疗组 | 19 | 17 | 13 | 1 | 38 | 98 |
对照组 | 8 | 5 | 12 | 25 | 16 | 50 |
与对照组比较,P<0.05。
由表3可知,治疗组治愈率38%,总有效率98%。而对照组治愈率16%,总有效率50%。可见,本发明的眼保健贴疗效明显优于对照组。
治疗组治疗过程中生命体征平稳且无过敏等严重不良反应,治疗结束后对治疗组患者的实验室指标血常规、大便常规、小便常规、心电图等进行统计学处理,未见明显异常。结果表明本发明的临床运用是安全有效的,值得进一步研究并推广应用。
需要说明的是,上述实施例仅仅是实现本发明的优选方式的部分实施例,而非全部实施例。显然,基于本发明的上述实施例,本领域普通技术人员在没有做出创造性劳动的前提下所获得的其他所有实施例,都应当属于本发明保护的范围。
Claims (5)
1.一种基于一氧化氮原理改善眼睛的中药眼保健贴,其特征在于,是由以下重量份的原料制成:人参160-200份、党参120-160份、密蒙花100-120份、鸡爪黄连80-100份、艾叶60-100份、黄柏60-100份、木贼50-70份、白菊花100-120份、川芎50-70份、夏枯草50-70份、桑叶50-70份、决明子60-100份、车前子60-100份、酒制蜂胶20-40份、防风20-40份、牛磺酸3-5份、亮氨酸3-7份、异亮氨酸3-7份、缬氨酸3-7份、酶解珍珠粉3-5份、蓝莓提取物3-5份、叶黄素3-5份、花青素4-8份、薄荷脑4-8份、冰片4-8份、苯甲酸纳3-5份和甘油6-10份。
2.根据权利要求1所述的中药眼保健贴,其特征在于,是由以下重量份的原料制成:人参180份、党参140份、密蒙花110份、鸡爪黄连90份、艾叶80份、黄柏80份、木贼60份、白菊花110份、川芎60份、夏枯草60份、桑叶60份、决明子80份、车前子80份、酒制蜂胶30份、防风30份、牛磺酸4份、亮氨酸5份、异亮氨酸5份、缬氨酸5份、酶解珍珠粉4份、蓝莓提取物4份、叶黄素4份、花青素6份、薄荷脑6份、冰片6份、苯甲酸纳4份和甘油8份。
3.根据权利要求1或2所述的中药眼保健贴,其特征在于,所述酒制蜂胶是由如下方法制得:将蜂胶用5倍重量份90-95%乙醇浸泡24-36小时,过滤,滤液经浓缩、干燥、粉碎和研磨后,过200目筛得酒制蜂胶。
4.根据权利要求1或2所述的中药眼保健贴,其特征在于,所述酶解珍珠粉为采用酶解工艺制备的超细珍珠粉,其粒径为80μm以下。
5.权利要求1或2所述的中药眼保健贴,其特征在于,其制备方法如下:
(1)按比例称取人参、党参、密蒙花、鸡爪黄连、艾叶、黄柏、木贼、白菊花、川芎、夏枯草、桑叶、决明子、车前子、酒制蜂胶和防风分别粉碎后加入5倍重量的蒸馏水,醇提水沉二次,合并提取液,取上清液,得到中草药混合液;
(2)按比例称取牛磺酸、亮氨酸、异亮氨酸、缬氨酸、酶解珍珠粉、蓝莓提取物、叶黄素、花青素、薄荷脑、冰片、苯甲酸纳和甘油加入到步骤(1)所得中药混合液,并加入两倍重量的蒸馏水,搅拌均匀,将切割成片的无纺布浸渍溶液中24-48小时,装袋封装后得到中药眼保健贴。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810696251.6A CN108498615A (zh) | 2018-06-29 | 2018-06-29 | 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810696251.6A CN108498615A (zh) | 2018-06-29 | 2018-06-29 | 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108498615A true CN108498615A (zh) | 2018-09-07 |
Family
ID=63403979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810696251.6A Pending CN108498615A (zh) | 2018-06-29 | 2018-06-29 | 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108498615A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110665109A (zh) * | 2019-10-29 | 2020-01-10 | 延安康亿健医药科技有限公司 | 明目护眼贴 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1872279A (zh) * | 2005-06-01 | 2006-12-06 | 江苏中康药物科技有限公司 | 一种治疗口腔溃疡的药物组合物及其制备方法 |
CN105362501A (zh) * | 2015-11-13 | 2016-03-02 | 关玉斌 | 一种防辐射保护视力的饮料及其制备方法 |
CN107029037A (zh) * | 2017-05-25 | 2017-08-11 | 上海诺鼎生物科技有限公司 | 一种基于一氧化氮原理改善眼睛的明目保健贴 |
-
2018
- 2018-06-29 CN CN201810696251.6A patent/CN108498615A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1872279A (zh) * | 2005-06-01 | 2006-12-06 | 江苏中康药物科技有限公司 | 一种治疗口腔溃疡的药物组合物及其制备方法 |
CN105362501A (zh) * | 2015-11-13 | 2016-03-02 | 关玉斌 | 一种防辐射保护视力的饮料及其制备方法 |
CN107029037A (zh) * | 2017-05-25 | 2017-08-11 | 上海诺鼎生物科技有限公司 | 一种基于一氧化氮原理改善眼睛的明目保健贴 |
Non-Patent Citations (3)
Title |
---|
曾立昆等: "《本草歌诀》", 31 July 2015, 人民军医出版社 * |
江省蓉等: "《图解保健食品全书》", 31 May 2015, 湖南科学技术出版社 * |
龚千锋: "《中药炮制学》", 31 August 2016, 中国中医药出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110665109A (zh) * | 2019-10-29 | 2020-01-10 | 延安康亿健医药科技有限公司 | 明目护眼贴 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102698079B (zh) | 一种治疗干眼症的药物组合物及其制备方法和用途 | |
US20210169779A1 (en) | Ophthalmic drug preparation and uses thereof | |
CN111035748A (zh) | 用于改善近视的中药组合物、用于改善近视的外敷制剂和用于改善近视的眼贴 | |
CN1830407A (zh) | 中药热疗眼罩及其药物 | |
CN101700336B (zh) | 一种治疗颅脑外伤后遗性头痛的中药制剂及其制备方法 | |
CN104971304A (zh) | 一种用于治疗干眼症的药物 | |
CN107137471A (zh) | 一种止痛中药组合物及其制备方法和应用 | |
CN108498615A (zh) | 一种基于一氧化氮原理改善眼睛的中药眼保健贴及其制备方法 | |
CN107029037A (zh) | 一种基于一氧化氮原理改善眼睛的明目保健贴 | |
CN110448618A (zh) | 一种治疗视力的中药配方及其制备方法 | |
CN112121104B (zh) | 一种缓解视疲劳及防治近视的中药组合物 | |
CN104306546B (zh) | 一种用于治疗视神经萎缩的中药组合物及其汤剂、丸剂和散剂 | |
CN1109786A (zh) | 脐疗明目袋的制造方法 | |
CN112933163A (zh) | 一种外用治疗视疲劳的中药组合物分类方法和中药眼贴 | |
CN110302357A (zh) | 一种外用明目保健中药组合物及其制备方法 | |
CN104096018A (zh) | 一种治疗面部神经麻痹症的中药组合物 | |
CN114796358B (zh) | 一种缓解视疲劳的中药组合物及其制备方法和应用 | |
CN115350230B (zh) | 一种预防近视的组方及制剂 | |
CN116211984B (zh) | 一种防治儿童青少年近视的中药组合物眼膏及其制备方法 | |
CN112274558B (zh) | 一种治疗眼袋、黑眼圈的药物组合物及其制备方法和用途 | |
CN110327433B (zh) | 一种使眼角上扬、眼部放松的液体制剂 | |
CN106177446B (zh) | 一种用于治疗特发性面神经麻痹的中药制剂 | |
CN106267023A (zh) | 一种用于视神经萎缩的活络明目丸 | |
CN104758494A (zh) | 一种用于原发性青光眼防盲的药剂 | |
CN118001317A (zh) | 一种治疗眼底黄斑变性的外敷中药、眼贴及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190117 Address after: Room 503, 5th floor, Daye Plaza, Jingheng, 2008, Shanghai Qingpu District, Shanghai Applicant after: Shanghai Yuanding Biotechnology Co., Ltd. Address before: 17th Floor, Building B, 500 Lane, Yunjin Road, Xuhui District, Shanghai, 2002 Applicant before: Zhang Biao |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |
|
RJ01 | Rejection of invention patent application after publication |